CLOFARABINE

CLOFARABINE was reported 2287 times

CLOFARABINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRANULICATELLA INFECTION 5 0.1190
1 IDH DIFFERENTIATION SYNDROME 2 0.0909
2 HUMAN HERPESVIRUS 6 VIRAEMIA 3 0.0750
3 ANAL FISTULA EXCISION 1 0.0714
4 DYSPONESIS 1 0.0667
5 BLEPHARITIS ALLERGIC 2 0.0645
6 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 7 0.0519
7 FUNGAL RASH 2 0.0476
8 TOXIC ERYTHEMA OF CHEMOTHERAPY 12 0.0463
9 DEMODICIDOSIS 4 0.0435
10 DECREASED VENTRICULAR PRELOAD 1 0.0417
11 ACHROMOBACTER INFECTION 5 0.0417
12 GRAFT VERSUS HOST DISEASE IN LIVER 28 0.0391
13 BLOOD BETA-D-GLUCAN POSITIVE 1 0.0385
14 LINEAGE SWITCH LEUKAEMIA 2 0.0377
15 FUSARIUM INFECTION 24 0.0343
16 PULMONARY SEPTAL THICKENING 3 0.0337
17 STENOTROPHOMONAS SEPSIS 4 0.0331
18 FUNGUS SPUTUM TEST POSITIVE 1 0.0323
19 ACUTE MYELOID LEUKAEMIA (IN REMISSION) 1 0.0294
20 ACUTE MYELOID LEUKAEMIA REFRACTORY 5 0.0291
21 BLAST CELL COUNT DECREASED 2 0.0274
22 BACTERIA SPUTUM IDENTIFIED 2 0.0263
23 HISTIOCYTIC SARCOMA 2 0.0256
24 ROSAI-DORFMAN SYNDROME 2 0.0253
25 PNEUMONIA ADENOVIRAL 5 0.0253
26 CAPILLARY LEAK SYNDROME 51 0.0246
27 EAR INFECTION STAPHYLOCOCCAL 3 0.0246
28 BONE MARROW LEUKAEMIC CELL INFILTRATION 2 0.0244
29 EPIPLOIC APPENDAGITIS 3 0.0234
30 LEUKOSTASIS SYNDROME 3 0.0226
31 ENTEROBACTER SEPSIS 8 0.0216
32 BLOOD PRESSURE SYSTOLIC INSPIRATORY DECREASED 1 0.0213
33 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 15 0.0209
34 METAPNEUMOVIRUS PNEUMONIA 2 0.0208
35 PYOMYOSITIS 6 0.0203
36 CULTURE THROAT POSITIVE 1 0.0196
37 LEUKAEMIA CUTIS 3 0.0195
38 GASTROENTERITIS ADENOVIRUS 3 0.0191
39 SINUSITIS ASPERGILLUS 3 0.0190
40 SERRATIA SEPSIS 2 0.0185
41 ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY 1 0.0185
42 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 24 0.0182
43 ACUTE MEGAKARYOCYTIC LEUKAEMIA 1 0.0182
44 APLASIA 35 0.0179
45 PNEUMONIA PARAINFLUENZAE VIRAL 3 0.0176
46 BLAST CELL PROLIFERATION 1 0.0175
47 INTRACARDIAC MASS 3 0.0169
48 ENTEROBACTER BACTERAEMIA 5 0.0165
49 ANORECTAL CELLULITIS 1 0.0164
50 ACQUIRED APPARENT MINERALOCORTICOID EXCESS 1 0.0161
51 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 34 0.0160
52 BACTERIA BLOOD IDENTIFIED 2 0.0153
53 STREPTOCOCCAL SEPSIS 18 0.0152
54 CORYNEBACTERIUM SEPSIS 1 0.0152
55 BLOOD BILIRUBIN 1 0.0149
56 GRAFT VERSUS HOST DISEASE IN SKIN 32 0.0145
57 ENDOTOXIC SHOCK 1 0.0145
58 ADENOVIRAL HAEMORRHAGIC CYSTITIS 3 0.0144
59 CELL-MEDIATED IMMUNE DEFICIENCY 2 0.0143
60 CEREBRAL FUNGAL INFECTION 4 0.0141
61 CORYNEBACTERIUM TEST POSITIVE 1 0.0141
62 REFRACTORY CANCER 3 0.0140
63 ADENOVIRUS INFECTION 40 0.0138
64 CLOSTRIDIUM DIFFICILE TOXIN TEST POSITIVE 2 0.0137
65 LEUKAEMIA RECURRENT 23 0.0136
66 CSF WHITE BLOOD CELL COUNT POSITIVE 1 0.0135
67 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 34 0.0132
68 CYTARABINE SYNDROME 1 0.0132
69 ZYGOMYCOSIS 6 0.0128
70 VENOOCCLUSIVE DISEASE 31 0.0124
71 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 11 0.0119
72 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 3 0.0118
73 CYTOKINE STORM 8 0.0117
74 VENTRICULAR ENLARGEMENT 2 0.0114
75 ENTEROCOCCAL BACTERAEMIA 12 0.0113
76 VIRAL HAEMORRHAGIC CYSTITIS 8 0.0112
77 HEPATOBILIARY DISEASE 7 0.0112
78 BRAF GENE MUTATION 1 0.0111
79 CULTURE STOOL POSITIVE 3 0.0109
80 VENOOCCLUSIVE LIVER DISEASE 53 0.0107
81 ACINETOBACTER BACTERAEMIA 2 0.0106
82 HUMAN HERPESVIRUS 6 ENCEPHALITIS 3 0.0106
83 BACTERIA STOOL IDENTIFIED 2 0.0105
84 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 29 0.0105
85 ACUTE GRAFT VERSUS HOST DISEASE 48 0.0105
86 BK POLYOMAVIRUS TEST POSITIVE 1 0.0104
87 ANAL RASH 1 0.0104
88 BONE MARROW INFILTRATION 4 0.0103
89 B PRECURSOR TYPE ACUTE LEUKAEMIA 4 0.0103
90 DUODENAL NEOPLASM 1 0.0102
91 ENGRAFTMENT SYNDROME 6 0.0102
92 ELECTROCARDIOGRAM Q WAVES 1 0.0098
93 T-CELL TYPE ACUTE LEUKAEMIA 2 0.0098
94 ACUTE LYMPHOCYTIC LEUKAEMIA 27 0.0095
95 CYTOMEGALOVIRUS INFECTION REACTIVATION 42 0.0095
96 CHLOROMA 4 0.0095
97 ALANINE AMINOTRANSFERASE 2 0.0090
98 MUCOCUTANEOUS ULCERATION 2 0.0088
99 DRUG HALF-LIFE INCREASED 1 0.0088
100 ENTEROCOCCAL SEPSIS 7 0.0086
101 PLEURAL INFECTION 2 0.0086
102 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 5 0.0085
103 FUNGAL SEPSIS 7 0.0084
104 ACUTE MYELOID LEUKAEMIA RECURRENT 18 0.0084
105 MINIMAL RESIDUAL DISEASE 4 0.0083
106 ASPARTATE AMINOTRANSFERASE 2 0.0082
107 REMISSION NOT ACHIEVED 5 0.0080
108 MENINGORRHAGIA 2 0.0080
109 BACTERIAL SEPSIS 26 0.0080
110 CSF TEST ABNORMAL 4 0.0080
111 CYSTITIS HAEMORRHAGIC 32 0.0079
112 SYSTEMIC MYCOSIS 9 0.0077
113 BACTEROIDES INFECTION 2 0.0077
114 OVARIAN FAILURE 4 0.0075
115 HAEMATOTOXICITY 71 0.0075
116 HUMAN HERPESVIRUS 6 INFECTION 14 0.0074
117 ATRIAL ENLARGEMENT 2 0.0074
118 PNEUMONIA FUNGAL 29 0.0073
119 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 6 0.0071
120 SKIN TOXICITY 40 0.0071
121 ADENOVIRUS REACTIVATION 1 0.0069
122 TOXIC LEUKOENCEPHALOPATHY 5 0.0069
123 PLEOCYTOSIS 4 0.0069
124 IDIOPATHIC PNEUMONIA SYNDROME 2 0.0067
125 CAECITIS 3 0.0067
126 FUNGAEMIA 10 0.0063
127 BACILLUS INFECTION 4 0.0063
128 NEUTROPENIC COLITIS 13 0.0063
129 GRAFT VERSUS HOST DISEASE 45 0.0063
130 SINUSITIS FUNGAL 5 0.0062
131 KLEBSIELLA SEPSIS 7 0.0062
132 ASPERGILLOSIS 8 0.0061
133 BLOOD CULTURE POSITIVE 18 0.0060
134 URETERIC OBSTRUCTION 8 0.0059
135 ENTEROCOCCAL INFECTION 28 0.0058
136 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0058
137 MYELODYSPLASTIC SYNDROME TRANSFORMATION 3 0.0058
138 STAPHYLOCOCCAL BACTERAEMIA 25 0.0057
139 PSEUDOMONAL SEPSIS 10 0.0057
140 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 8 0.0057
141 POLYOMAVIRUS VIRAEMIA 6 0.0056
142 PERIORBITAL CELLULITIS 3 0.0056
143 CANDIDA SEPSIS 5 0.0056
144 ESCHERICHIA SEPSIS 16 0.0055
145 ACUTE MONOCYTIC LEUKAEMIA 1 0.0055
146 STAPHYLOCOCCAL SEPSIS 27 0.0055
147 CENTRAL LINE INFECTION 2 0.0054
148 BK VIRUS INFECTION 18 0.0053
149 CELLULITIS GANGRENOUS 1 0.0051
150 CHRONIC GRAFT VERSUS HOST DISEASE 18 0.0050
151 LYMPHOCYTIC LEUKAEMIA 2 0.0049
152 UREAPLASMA INFECTION 2 0.0049
153 MUCOSAL INFLAMMATION 128 0.0049
154 POST LUMBAR PUNCTURE SYNDROME 5 0.0048
155 ELECTROCARDIOGRAM PR SHORTENED 1 0.0048
156 TRANSPLANTATION COMPLICATION 2 0.0048
157 NEUTROPENIC SEPSIS 34 0.0048
158 ARTERITIS 3 0.0047
159 PSEUDOMONAL BACTERAEMIA 4 0.0047
160 FRONTOTEMPORAL DEMENTIA 2 0.0047
161 CORONA VIRUS INFECTION 2 0.0047
162 PARAINFLUENZAE VIRUS INFECTION 7 0.0046
163 ENCEPHALITIS CYTOMEGALOVIRUS 2 0.0046
164 HYPOGAMMAGLOBULINAEMIA 30 0.0046
165 SYSTEMIC CANDIDA 11 0.0044
166 GRAFT VERSUS HOST DISEASE IN EYE 1 0.0043
167 ADENOVIRAL HEPATITIS 1 0.0043
168 CEREBRAL MICROANGIOPATHY 1 0.0042
169 NEUTROPENIC INFECTION 4 0.0042
170 BONE MARROW FAILURE 84 0.0041
171 BONE MARROW DEPRESSION 4 0.0041
172 FEBRILE NEUTROPENIA 270 0.0041
173 EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER 2 0.0041
174 HYPERBILIRUBINAEMIA 42 0.0041
175 MULTI-ORGAN FAILURE 68 0.0039
176 B-CELL APLASIA 1 0.0039
177 ACUTE MYELOID LEUKAEMIA 60 0.0038
178 ENDOCARDITIS BACTERIAL 3 0.0038
179 BLOOD CORTISOL INCREASED 1 0.0038
180 INTERVERTEBRAL DISCITIS 7 0.0037
181 GONORRHOEA 1 0.0037
182 TOXOPLASMOSIS 4 0.0037
183 STENOTROPHOMONAS INFECTION 5 0.0037
184 STREPTOCOCCAL BACTERAEMIA 4 0.0037
185 ANAL ULCER 3 0.0037
186 ACINETOBACTER INFECTION 4 0.0037
187 QUADRIPARESIS 6 0.0036
188 EPSTEIN-BARR VIRAEMIA 4 0.0036
189 CULTURE POSITIVE 3 0.0036
190 BLOOD BILIRUBIN INCREASED 97 0.0036
191 BRAIN SCAN ABNORMAL 2 0.0036
192 GASTROINTESTINAL BACTERIAL INFECTION 4 0.0035
193 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
194 CATHETER SITE CELLULITIS 1 0.0034
195 NEPHRECTOMY 5 0.0034
196 ENTEROCOLITIS VIRAL 1 0.0033
197 PITTING OEDEMA 2 0.0033
198 TRANSPLANT FAILURE 8 0.0033
199 ENTEROCOLITIS INFECTIOUS 3 0.0033
200 ASPERGILLUS TEST POSITIVE 1 0.0032
201 GASTROENTERITIS ROTAVIRUS 1 0.0032
202 NEURODEGENERATIVE DISORDER 2 0.0032
203 CEREBRAL TOXOPLASMOSIS 3 0.0032
204 STEM CELL TRANSPLANT 8 0.0032
205 MULTIPLE ORGAN DYSFUNCTION SYNDROME 90 0.0032
206 EPSTEIN-BARR VIRUS TEST POSITIVE 2 0.0032
207 ECHOLALIA 1 0.0031
208 ANAL INFLAMMATION 2 0.0031
209 BRONCHOPULMONARY ASPERGILLOSIS 24 0.0031
210 ENTEROCOCCUS TEST POSITIVE 2 0.0031
211 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 1 0.0030
212 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 2 0.0030
213 ESCHERICHIA BACTERAEMIA 7 0.0030
214 BRAIN MASS 1 0.0030
215 NEPHROPATHY TOXIC 33 0.0029
216 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 1 0.0029
217 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 68 0.0029
218 TENOSYNOVITIS 8 0.0029
219 PULMONARY VENO-OCCLUSIVE DISEASE 2 0.0029
220 FUNGAL TEST POSITIVE 1 0.0028
221 ELECTROCARDIOGRAM ST-T CHANGE 2 0.0028
222 PROTEUS INFECTION 2 0.0028
223 COMPLICATIONS OF BONE MARROW TRANSPLANT 1 0.0028
224 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0027
225 ERYTHROMELALGIA 1 0.0027
226 AORTIC VALVE SCLEROSIS 2 0.0027
227 BRONCHOPNEUMOPATHY 1 0.0027
228 HEPATITIS FULMINANT 8 0.0027
229 HEPATOTOXICITY 60 0.0027
230 BODY DYSMORPHIC DISORDER 1 0.0027
231 MYELOPATHY 5 0.0026
232 CENTRAL NERVOUS SYSTEM INFECTION 3 0.0026
233 CYSTITIS VIRAL 1 0.0026
234 CARBON DIOXIDE DECREASED 3 0.0026
235 GENITAL ULCERATION 2 0.0026
236 OLIGURIA 16 0.0026
237 PULMONARY MYCOSIS 2 0.0026
238 CENTRAL NERVOUS SYSTEM LEUKAEMIA 1 0.0025
239 BONE MARROW TOXICITY 3 0.0025
240 EYE INFECTION TOXOPLASMAL 1 0.0025
241 TUMOUR LYSIS SYNDROME 22 0.0025
242 CLOSTRIDIUM COLITIS 3 0.0025
243 CYTOMEGALOVIRUS VIRAEMIA 11 0.0025
244 SPUTUM CULTURE POSITIVE 2 0.0025
245 CARDIAC VENTRICULAR DISORDER 1 0.0024
246 PERITONSILLAR ABSCESS 2 0.0024
247 ENTEROBACTER INFECTION 4 0.0024
248 CEREBRAL VENOUS SINUS THROMBOSIS 2 0.0024
249 OESOPHAGEAL ULCER 9 0.0023
250 ENDOCRINE DISORDER 3 0.0023
251 TRANSAMINASES INCREASED 52 0.0023
252 VENTRICULAR DYSFUNCTION 6 0.0023
253 HERPES SIMPLEX 15 0.0023
254 PULMONARY HAEMORRHAGE 18 0.0023
255 AXONAL NEUROPATHY 2 0.0023
256 TRANSFUSION REACTION 2 0.0023
257 ILEUS PARALYTIC 10 0.0022
258 COMPUTERISED TOMOGRAM ABNORMAL 5 0.0022
259 BIOPSY BONE MARROW ABNORMAL 1 0.0022
260 INTESTINAL INFARCTION 2 0.0022
261 EPIDERMOLYSIS 1 0.0022
262 VIRAEMIA 3 0.0022
263 CEREBRAL HYPOPERFUSION 1 0.0021
264 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 1 0.0021
265 URINARY TRACT INFECTION ENTEROCOCCAL 2 0.0021
266 ASPERGILLUS INFECTION 14 0.0021
267 HAEMATOLOGICAL MALIGNANCY 6 0.0021
268 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 20 0.0021
269 BLAST CELLS PRESENT 1 0.0021
270 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
271 ARTERIOVENOUS FISTULA 1 0.0020
272 ENCEPHALITIS HERPES 1 0.0020
273 MUCOSAL ULCERATION 2 0.0020
274 CATHETER RELATED INFECTION 2 0.0020
275 EPSTEIN-BARR VIRUS INFECTION 12 0.0019
276 BLAST CELL COUNT INCREASED 2 0.0019
277 LUNG ABSCESS 4 0.0019
278 HYPOPERFUSION 2 0.0019
279 GASTRIC ANTRAL VASCULAR ECTASIA 1 0.0019
280 PSEUDOMONAS INFECTION 16 0.0019
281 BLOOD GASES ABNORMAL 1 0.0019
282 RESPIRATORY ALKALOSIS 3 0.0018
283 KIDNEY ENLARGEMENT 2 0.0018
284 OCULAR TOXICITY 2 0.0018
285 PANCYTOPENIA 100 0.0018
286 LUNG CONSOLIDATION 5 0.0018
287 ENCEPHALOMALACIA 1 0.0018
288 PNEUMATOSIS INTESTINALIS 5 0.0018
289 INFECTION REACTIVATION 2 0.0017
290 CANDIDIASIS 7 0.0017
291 HYPERAMMONAEMIC ENCEPHALOPATHY 3 0.0017
292 CELLULITIS ORBITAL 1 0.0017
293 LABILE BLOOD PRESSURE 2 0.0017
294 CYTOMEGALOVIRUS INFECTION 28 0.0017
295 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
296 PNEUMONIA INFLUENZAL 2 0.0017
297 DERMO-HYPODERMITIS 1 0.0017
298 SEPTIC SHOCK 73 0.0017
299 ENCEPHALITIS VIRAL 2 0.0016
300 SOFT TISSUE INFECTION 3 0.0016
301 CEREBRAL ASPERGILLOSIS 1 0.0016
302 OPPORTUNISTIC INFECTION 3 0.0016
303 MULTIPLE-DRUG RESISTANCE 5 0.0016
304 BACTERIAL INFECTION 30 0.0016
305 URINARY TRACT INFECTION BACTERIAL 4 0.0016
306 BONE MARROW TRANSPLANT 3 0.0016
307 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
308 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
309 NOCARDIOSIS 4 0.0016
310 HEPATOSPLENOMEGALY 4 0.0016
311 STAPHYLOCOCCAL INFECTION 51 0.0015
312 CYTOKINE RELEASE SYNDROME 31 0.0015
313 MUCORMYCOSIS 4 0.0015
314 DRUG CLEARANCE DECREASED 2 0.0015
315 NON-HODGKIN'S LYMPHOMA 2 0.0015
316 ASPARTATE AMINOTRANSFERASE INCREASED 81 0.0015
317 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
318 HERPES OPHTHALMIC 2 0.0015
319 CARDIAC TAMPONADE 7 0.0015
320 ENCEPHALOPATHY 36 0.0015
321 CUTANEOUS SYMPTOM 1 0.0015
322 ARTHRITIS BACTERIAL 6 0.0015
323 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
324 OEDEMA 79 0.0015
325 RENAL MASS 3 0.0015
326 GUILLAIN-BARRE SYNDROME 7 0.0014
327 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
328 BACTERAEMIA 17 0.0014
329 PERIPHERAL MOTOR NEUROPATHY 2 0.0014
330 SEPSIS 159 0.0014
331 CULTURE URINE POSITIVE 2 0.0014
332 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
333 MYELITIS TRANSVERSE 2 0.0014
334 PULMONARY TOXICITY 10 0.0014
335 ALANINE AMINOTRANSFERASE INCREASED 86 0.0014
336 CEREBELLAR HAEMORRHAGE 2 0.0014
337 HYPERPHOSPHATAEMIA 3 0.0014
338 KLEBSIELLA INFECTION 7 0.0014
339 BACTERIAL DISEASE CARRIER 1 0.0014
340 B-CELL TYPE ACUTE LEUKAEMIA 1 0.0014
341 AMINO ACID LEVEL INCREASED 1 0.0013
342 BACTERIAL TEST POSITIVE 3 0.0013
343 METABOLIC ENCEPHALOPATHY 4 0.0013
344 CHLAMYDIAL INFECTION 1 0.0013
345 TOXIC EPIDERMAL NECROLYSIS 20 0.0013
346 CHEST X-RAY ABNORMAL 4 0.0013
347 HYPERTRANSAMINASAEMIA 9 0.0013
348 RHINOVIRUS INFECTION 5 0.0013
349 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 3 0.0013
350 RENAL FAILURE ACUTE 54 0.0013
351 BRONCHIAL CARCINOMA 1 0.0013
352 ELECTROMECHANICAL DISSOCIATION 1 0.0013
353 GASTROINTESTINAL TOXICITY 6 0.0012
354 ACUTE LEUKAEMIA 2 0.0012
355 VASOPLEGIA SYNDROME 2 0.0012
356 HYPERURICAEMIA 5 0.0012
357 HERPES VIRUS INFECTION 7 0.0012
358 COLLAPSE OF LUNG 1 0.0012
359 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 9 0.0012
360 HAEMODIALYSIS 10 0.0012
361 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 6 0.0012
362 ACIDOSIS 9 0.0012
363 BLOOD PH DECREASED 2 0.0012
364 PUPIL FIXED 2 0.0012
365 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
366 MONOPARESIS 2 0.0011
367 DERMATITIS BULLOUS 8 0.0011
368 ARTERIOVENOUS MALFORMATION 1 0.0011
369 BLOOD PHOSPHORUS INCREASED 3 0.0011
370 LUNG INFECTION 17 0.0011
371 ESCHERICHIA INFECTION 9 0.0011
372 PNEUMONIA KLEBSIELLA 2 0.0011
373 PLEURITIC PAIN 3 0.0011
374 NEUROTOXICITY 19 0.0011
375 AMYLASE INCREASED 4 0.0011
376 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0011
377 COAGULOPATHY 18 0.0011
378 PULMONARY ALVEOLAR HAEMORRHAGE 6 0.0011
379 LIPASE INCREASED 8 0.0010
380 HYPOREFLEXIA 2 0.0010
381 RESPIRATORY FAILURE 76 0.0010
382 COLON NEOPLASM 1 0.0010
383 FLUID OVERLOAD 15 0.0010
384 THROMBOTIC MICROANGIOPATHY 10 0.0010
385 CARDIOPULMONARY FAILURE 4 0.0010
386 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
387 HYPOVOLAEMIA 6 0.0010
388 GASTROINTESTINAL INFLAMMATION 8 0.0010
389 PYELONEPHRITIS ACUTE 2 0.0010
390 DACTYLITIS 1 0.0010
391 ACUTE RESPIRATORY DISTRESS SYNDROME 18 0.0010
392 ENCEPHALITIS 7 0.0010
393 HYPERVOLAEMIA 5 0.0010
394 HYPERAMMONAEMIA 5 0.0010
395 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
396 DEVICE RELATED SEPSIS 2 0.0010
397 AUTONOMIC NEUROPATHY 1 0.0010
398 MALNUTRITION 11 0.0010
399 GENERALISED OEDEMA 12 0.0010
400 ATRIAL THROMBOSIS 2 0.0010
401 EMBOLISM 8 0.0010
402 DILATATION VENTRICULAR 2 0.0010
403 ABDOMINAL ADHESIONS 3 0.0009
404 FEBRILE BONE MARROW APLASIA 4 0.0009
405 LUNG NEOPLASM 4 0.0009
406 VENTRICULAR HYPOKINESIA 3 0.0009
407 ATELECTASIS 9 0.0009
408 FUNGAL INFECTION 31 0.0009
409 HAEMORRHAGIC DISORDER 1 0.0009
410 RESPIRATORY SYNCYTIAL VIRUS INFECTION 8 0.0009
411 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
412 NEUTROPENIA 124 0.0009
413 CLOSTRIDIUM TEST POSITIVE 2 0.0009
414 LUNG INFILTRATION 8 0.0009
415 MYELODYSPLASTIC SYNDROME 13 0.0009
416 PNEUMOCYSTIS JIROVECI PNEUMONIA 2 0.0009
417 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
418 CLOSTRIDIAL INFECTION 3 0.0009
419 ACUTE PRERENAL FAILURE 1 0.0009
420 DRUG RESISTANCE 22 0.0009
421 DIALYSIS 12 0.0008
422 TRANSPLANT 2 0.0008
423 PULSE ABSENT 4 0.0008
424 ESCHERICHIA TEST POSITIVE 1 0.0008
425 CEREBRAL ARTERY EMBOLISM 1 0.0008
426 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 1 0.0008
427 ORGANISING PNEUMONIA 4 0.0008
428 ABDOMINAL TENDERNESS 4 0.0008
429 HYPERNATRAEMIA 4 0.0008
430 DERMATITIS EXFOLIATIVE 4 0.0008
431 PROTEIN TOTAL DECREASED 3 0.0008
432 HYPOXIA 28 0.0008
433 TOXIC ENCEPHALOPATHY 4 0.0008
434 CARDIOTOXICITY 7 0.0008
435 FAILURE TO THRIVE 4 0.0008
436 RESPIRATORY ACIDOSIS 3 0.0008
437 RESPIRATORY DISTRESS 21 0.0008
438 EXTRADURAL HAEMATOMA 1 0.0008
439 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
440 THROMBOCYTOPENIA 83 0.0007
441 EFFUSION 1 0.0007
442 STOMA SITE DISCHARGE 2 0.0007
443 PLEURAL EFFUSION 44 0.0007
444 NECROSIS 4 0.0007
445 DEVICE RELATED INFECTION 11 0.0007
446 ASCITES 21 0.0007
447 PROCTITIS 2 0.0007
448 BRONCHIAL OBSTRUCTION 1 0.0007
449 H1N1 INFLUENZA 1 0.0007
450 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
451 FANCONI SYNDROME 1 0.0007
452 CARDIAC FAILURE CHRONIC 3 0.0007
453 RETINAL HAEMORRHAGE 5 0.0007
454 HEPATIC FAILURE 21 0.0007
455 HEPATIC LESION 3 0.0007
456 PARAPLEGIA 2 0.0007
457 ENTEROCOLITIS 4 0.0007
458 PERICARDIAL EFFUSION 16 0.0007
459 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
460 BILIARY DILATATION 1 0.0007
461 RASH MACULO-PAPULAR 15 0.0007
462 CREPITATIONS 2 0.0007
463 BRAIN HERNIATION 2 0.0007
464 GASTROINTESTINAL WALL THICKENING 1 0.0007
465 MIXED LIVER INJURY 2 0.0007
466 NO THERAPEUTIC RESPONSE 8 0.0007
467 BLOOD PRESSURE IMMEASURABLE 1 0.0007
468 ISCHAEMIA 3 0.0007
469 DYSAESTHESIA 2 0.0007
470 CEREBRAL HAEMORRHAGE 23 0.0006
471 BLOOD CREATININE DECREASED 2 0.0006
472 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
473 LEUKAEMIA 6 0.0006
474 SUBDURAL HAEMATOMA 9 0.0006
475 ATRIAL FLUTTER 5 0.0006
476 THERAPY NON-RESPONDER 28 0.0006
477 RENAL TUBULAR NECROSIS 6 0.0006
478 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
479 EYELID OEDEMA 7 0.0006
480 SPLENOMEGALY 7 0.0006
481 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
482 PYREXIA 206 0.0006
483 NEOPLASM RECURRENCE 2 0.0006
484 TACHYPNOEA 8 0.0006
485 PETIT MAL EPILEPSY 3 0.0006
486 CIRCULATORY COLLAPSE 10 0.0006
487 GAZE PALSY 1 0.0006
488 POLYNEUROPATHY 7 0.0006
489 BLOOD AMYLASE INCREASED 1 0.0006
490 BLOOD CHLORIDE INCREASED 1 0.0006
491 SKIN NECROSIS 3 0.0006
492 MENTAL STATUS CHANGES 16 0.0006
493 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
494 GASTROINTESTINAL OEDEMA 1 0.0006
495 ILEUS 7 0.0006
496 COLITIS 21 0.0006
497 DISEASE PROGRESSION 65 0.0005
498 CONDUCTION DISORDER 1 0.0005
499 PNEUMONIA BACTERIAL 5 0.0005
500 GRANULOCYTE COUNT DECREASED 1 0.0005
501 STREPTOCOCCAL INFECTION 3 0.0005
502 LEUKOENCEPHALOPATHY 2 0.0005
503 ACUTE PULMONARY OEDEMA 3 0.0005
504 CANDIDA INFECTION 9 0.0005
505 HEPATIC NECROSIS 2 0.0005
506 CHOLECYSTITIS ACUTE 3 0.0005
507 CATHETER SITE INFECTION 2 0.0005
508 BLOOD BICARBONATE DECREASED 1 0.0005
509 GRANULOCYTOPENIA 3 0.0005
510 HAEMODYNAMIC INSTABILITY 4 0.0005
511 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
512 ACUTE RESPIRATORY FAILURE 10 0.0005
513 RALES 3 0.0005
514 HYPOALBUMINAEMIA 4 0.0005
515 PULMONARY OEDEMA 23 0.0005
516 ACUTE HEPATIC FAILURE 7 0.0005
517 STOMATITIS 31 0.0005
518 HEPATOMEGALY 5 0.0005
519 DRUG ERUPTION 9 0.0005
520 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
521 GENE MUTATION 1 0.0005
522 CELL DEATH 1 0.0005
523 TRICUSPID VALVE INCOMPETENCE 4 0.0005
524 CEREBRAL ATROPHY 2 0.0005
525 HEPATITIS CHOLESTATIC 3 0.0005
526 ADRENAL INSUFFICIENCY 6 0.0005
527 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
528 PERIPHERAL ISCHAEMIA 2 0.0005
529 DEMYELINATION 2 0.0005
530 CARDIOMEGALY 6 0.0005
531 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
532 ATRIAL TACHYCARDIA 1 0.0005
533 RENAL FAILURE 63 0.0005
534 CARDIOMYOPATHY 7 0.0005
535 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
536 ACUTE KIDNEY INJURY 72 0.0005
537 ANAEMIA MACROCYTIC 1 0.0005
538 HAEMORRHAGE INTRACRANIAL 7 0.0005
539 EXOPHTHALMOS 1 0.0005
540 RENAL IMPAIRMENT 39 0.0005
541 OCULAR ICTERUS 2 0.0005
542 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
543 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
544 BLOOD CREATINE INCREASED 2 0.0005
545 MENINGITIS ASEPTIC 2 0.0004
546 PATHOGEN RESISTANCE 4 0.0004
547 METABOLIC ACIDOSIS 14 0.0004
548 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 24 0.0004
549 CYTOMEGALOVIRUS COLITIS 1 0.0004
550 HAEMANGIOMA 1 0.0004
551 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
552 CARDIO-RESPIRATORY ARREST 18 0.0004
553 HYPOTENSION 86 0.0004
554 INFECTION 62 0.0004
555 BILIRUBIN CONJUGATED INCREASED 1 0.0004
556 HEPATOCELLULAR INJURY 6 0.0004
557 HYPOCALCAEMIA 8 0.0004
558 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
559 DIABETES INSIPIDUS 1 0.0004
560 BRONCHITIS CHRONIC 1 0.0004
561 HAEMATOLOGICAL INFECTION 1 0.0004
562 EYE OEDEMA 1 0.0004
563 HYPOPHOSPHATAEMIA 3 0.0004
564 NEOPLASM PROGRESSION 14 0.0004
565 HEPATIC FUNCTION ABNORMAL 15 0.0004
566 TREATMENT FAILURE 33 0.0004
567 HYPERTHERMIA 3 0.0004
568 SUBARACHNOID HAEMORRHAGE 4 0.0004
569 PRODUCT USE IN UNAPPROVED INDICATION 97 0.0004
570 DIFFUSE LARGE B-CELL LYMPHOMA 3 0.0004
571 MYELOSUPPRESSION 14 0.0004
572 AORTIC ARTERIOSCLEROSIS 1 0.0004
573 BLOOD CHLORIDE DECREASED 1 0.0004
574 LUNG DISORDER 19 0.0004
575 NERVOUS SYSTEM DISORDER 12 0.0004
576 COMPARTMENT SYNDROME 1 0.0004
577 EXFOLIATIVE RASH 1 0.0004
578 AREFLEXIA 1 0.0004
579 ANAL FISSURE 2 0.0004
580 ATRIAL FIBRILLATION 36 0.0004
581 DECUBITUS ULCER 3 0.0004
582 NEUTROPHIL COUNT DECREASED 15 0.0004
583 PNEUMONITIS 10 0.0004
584 PLATELET COUNT DECREASED 39 0.0004
585 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
586 HYPERKERATOSIS 2 0.0004
587 ACUTE CORONARY SYNDROME 3 0.0004
588 CHOLECYSTITIS INFECTIVE 1 0.0004
589 TACHYCARDIA 32 0.0004
590 PERICARDITIS 6 0.0004
591 MITRAL VALVE INCOMPETENCE 4 0.0004
592 GENERALISED ERYTHEMA 2 0.0004
593 MYOCARDIAL ISCHAEMIA 4 0.0004
594 CARDIAC ARREST 29 0.0004
595 DRUG-INDUCED LIVER INJURY 11 0.0004
596 HAEMATURIA 12 0.0004
597 HYPERTONIA 2 0.0003
598 ANURIA 3 0.0003
599 NEUROPATHY PERIPHERAL 33 0.0003
600 BLOOD URIC ACID INCREASED 2 0.0003
601 PYELONEPHRITIS 3 0.0003
602 COMA SCALE ABNORMAL 1 0.0003
603 URINE OUTPUT DECREASED 3 0.0003
604 COVID-19 PNEUMONIA 4 0.0003
605 RESPIRATORY RATE INCREASED 3 0.0003
606 CARDIAC FAILURE 27 0.0003
607 PULMONARY HYPERTENSION 7 0.0003
608 ODYNOPHAGIA 2 0.0003
609 CEREBROVASCULAR DISORDER 1 0.0003
610 OSTEOMYELITIS 6 0.0003
611 PLATELET COUNT ABNORMAL 2 0.0003
612 LUPUS-LIKE SYNDROME 3 0.0003
613 VIRAL INFECTION 11 0.0003
614 HYPOKALAEMIA 15 0.0003
615 GRAND MAL CONVULSION 3 0.0003
616 PIGMENTATION DISORDER 2 0.0003
617 HAEMOPTYSIS 9 0.0003
618 APPENDICITIS 3 0.0003
619 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
620 BILE DUCT STONE 1 0.0003
621 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
622 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
623 PROCTALGIA 2 0.0003
624 CYTOLYTIC HEPATITIS 1 0.0003
625 EYE HAEMORRHAGE 4 0.0003
626 BLOOD UREA INCREASED 5 0.0003
627 TOXIC SKIN ERUPTION 3 0.0003
628 B-CELL LYMPHOMA 1 0.0003
629 DRUG TOXICITY 4 0.0003
630 BRONCHOPNEUMONIA 1 0.0003
631 ECCHYMOSIS 2 0.0003
632 DIFFICULTY IN WALKING 1 0.0003
633 BLOOD CREATININE ABNORMAL 1 0.0003
634 TENDERNESS 3 0.0003
635 PETECHIAE 3 0.0003
636 PNEUMONIA 92 0.0003
637 BRONCHIOLITIS 1 0.0003
638 SUDDEN DEATH 3 0.0003
639 OFF LABEL USE 247 0.0003
640 SINUS TACHYCARDIA 4 0.0003
641 FIBRIN D DIMER INCREASED 1 0.0003
642 CARDIOGENIC SHOCK 4 0.0003
643 FACIAL BONES FRACTURE 1 0.0003
644 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
645 OESOPHAGITIS 3 0.0003
646 HYPERGLYCAEMIA 10 0.0003
647 CUTANEOUS VASCULITIS 1 0.0003
648 ASPIRATION 3 0.0003
649 BLOOD PHOSPHORUS DECREASED 1 0.0003
650 DISEASE RECURRENCE 13 0.0003
651 FOOD INTOLERANCE 1 0.0003
652 UNRESPONSIVE TO STIMULI 7 0.0003
653 VENTRICULAR FIBRILLATION 3 0.0003
654 SKIN INFECTION 3 0.0003
655 BLOOD POTASSIUM DECREASED 8 0.0003
656 CHEMOTHERAPY 1 0.0003
657 FACE INJURY 1 0.0003
658 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
659 CONVULSION 15 0.0003
660 COMMUNICATION DISORDER 1 0.0003
661 PROCEDURAL COMPLICATION 2 0.0003
662 CHOLESTASIS 5 0.0003
663 CELLULITIS 13 0.0003
664 APNOEA 2 0.0003
665 THERAPY PARTIAL RESPONDER 4 0.0003
666 SKIN LESION 7 0.0003
667 BLOOD ALBUMIN DECREASED 2 0.0003
668 GENERAL PHYSICAL HEALTH DETERIORATION 29 0.0003
669 AZOTAEMIA 1 0.0003
670 TRANSPLANT REJECTION 2 0.0002
671 HIP FRACTURE 8 0.0002
672 HEPATITIS C 3 0.0002
673 FUNGAL SKIN INFECTION 1 0.0002
674 SHOCK HAEMORRHAGIC 2 0.0002
675 BODY TEMPERATURE INCREASED 5 0.0002
676 CYTOPENIA 3 0.0002
677 HICCUPS 2 0.0002
678 TOXICITY TO VARIOUS AGENTS 41 0.0002
679 HALLUCINATIONS, MIXED 1 0.0002
680 FACE OEDEMA 4 0.0002
681 AORTIC VALVE INCOMPETENCE 1 0.0002
682 ABSCESS LIMB 1 0.0002
683 SKIN HYPERPIGMENTATION 2 0.0002
684 MYOPATHY 2 0.0002
685 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
686 OEDEMA PERIPHERAL 28 0.0002
687 ORTHOSTATIC HYPOTENSION 4 0.0002
688 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
689 DISORIENTATION 9 0.0002
690 BRADYCARDIA 12 0.0002
691 PURPURA 2 0.0002
692 RASH PAPULAR 5 0.0002
693 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
694 DISEASE COMPLICATION 1 0.0002
695 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
696 BLOOD CREATININE INCREASED 14 0.0002
697 VOMITING 100 0.0002
698 LACERATION 2 0.0002
699 LYMPHOPENIA 3 0.0002
700 ANAEMIA 40 0.0002
701 LETHARGY 12 0.0002
702 LIVER FUNCTION TEST ABNORMAL 6 0.0002
703 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
704 BREATH SOUNDS ABNORMAL 1 0.0002
705 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
706 HEPATIC ENZYME ABNORMAL 1 0.0002
707 FLUID INTAKE REDUCED 1 0.0002
708 EYELID PTOSIS 2 0.0002
709 DRUG LEVEL DECREASED 2 0.0002
710 OXYGEN SATURATION DECREASED 11 0.0002
711 SINUSITIS 20 0.0002
712 CEREBRAL ISCHAEMIA 1 0.0002
713 INFLAMMATION 10 0.0002
714 HEPATIC ENZYME INCREASED 13 0.0002
715 CATATONIA 1 0.0002
716 BLOOD LACTIC ACID INCREASED 1 0.0002
717 SKIN EXFOLIATION 16 0.0002
718 PANCREATITIS 10 0.0002
719 ANAL FISTULA 1 0.0002
720 PRODUCT USE ISSUE 35 0.0002
721 DYSARTHRIA 7 0.0002
722 ANAL ABSCESS 1 0.0002
723 WHITE BLOOD CELL COUNT DECREASED 20 0.0002
724 WOUND INFECTION 2 0.0002
725 FAECALOMA 1 0.0002
726 PHOTOSENSITIVITY REACTION 3 0.0002
727 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
728 GASTRIC ULCER HAEMORRHAGE 1 0.0002
729 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
730 BLISTER 10 0.0002
731 HEMIPARESIS 3 0.0002
732 STATUS EPILEPTICUS 2 0.0002
733 PAIN IN JAW 5 0.0002
734 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
735 HERPES ZOSTER 10 0.0002
736 GASTRIC HAEMORRHAGE 2 0.0002
737 RENAL DISORDER 8 0.0002
738 VASCULITIS 2 0.0002
739 LYMPHOCYTE COUNT DECREASED 3 0.0002
740 LYMPHADENOPATHY 6 0.0002
741 RESPIRATORY DISORDER 5 0.0002
742 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
743 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
744 LEUKOCYTOSIS 3 0.0002
745 SEIZURE 19 0.0002
746 DERMATITIS ACNEIFORM 1 0.0002
747 DECREASED APPETITE 38 0.0002
748 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
749 LEUKOPENIA 8 0.0002
750 MYDRIASIS 2 0.0002
751 HAEMOGLOBIN DECREASED 16 0.0002
752 ORAL HERPES 3 0.0002
753 RESPIRATORY TRACT INFECTION 4 0.0002
754 SINUS DISORDER 3 0.0002
755 HAEMATOCRIT DECREASED 3 0.0002
756 DRUG INEFFECTIVE 199 0.0002
757 APPETITE DISORDER 1 0.0002
758 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
759 QUALITY OF LIFE DECREASED 2 0.0001
760 JAUNDICE 4 0.0001
761 CONFUSIONAL STATE 24 0.0001
762 COLITIS ISCHAEMIC 1 0.0001
763 ABDOMINAL PAIN 34 0.0001
764 DRUG INTERACTION 23 0.0001
765 DELIRIUM 5 0.0001
766 HYPOMAGNESAEMIA 2 0.0001
767 BLOOD TEST ABNORMAL 2 0.0001
768 NAUSEA 111 0.0001
769 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
770 PSYCHOTIC DISORDER 4 0.0001
771 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
772 PULMONARY MASS 2 0.0001
773 PANCREATITIS ACUTE 3 0.0001
774 HYPERTENSION 28 0.0001
775 EPILEPSY 4 0.0001
776 SHOCK 3 0.0001
777 DRUG ADMINISTRATION ERROR 4 0.0001
778 HAEMOLYSIS 1 0.0001
779 EJECTION FRACTION DECREASED 2 0.0001
780 DEHYDRATION 17 0.0001
781 ARRHYTHMIA 6 0.0001
782 COMA 6 0.0001
783 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
784 DYSPNOEA 71 0.0001
785 ABSCESS 2 0.0001
786 BLOOD DISORDER 1 0.0001
787 HAEMORRHAGE 13 0.0001
788 INTERSTITIAL LUNG DISEASE 6 0.0001
789 NEURALGIA 3 0.0001
790 BLOOD POTASSIUM INCREASED 2 0.0001
791 DEATH 106 0.0001
792 SWELLING FACE 8 0.0001
793 CEREBRAL INFARCTION 3 0.0001
794 ERYTHEMA 25 0.0001
795 RASH 53 0.0001
796 SYNCOPE 12 0.0001
797 RHABDOMYOLYSIS 5 0.0001
798 URINARY RETENTION 4 0.0001
799 CHILLS 14 0.0001
800 HAEMATEMESIS 3 0.0001
801 FACIAL PARALYSIS 1 0.0001
802 HEPATITIS 3 0.0001
803 RECTAL HAEMORRHAGE 5 0.0001
804 HAEMATOMA 3 0.0001
805 LOCAL SWELLING 2 0.0001
806 GASTRITIS 3 0.0001
807 GROIN PAIN 1 0.0001
808 CHEST PAIN 21 0.0001
809 CARDIAC FAILURE CONGESTIVE 9 0.0001
810 GASTROINTESTINAL INFECTION 1 0.0001
811 DIARRHOEA 72 0.0001
812 RESTLESSNESS 4 0.0001
813 AGITATION 8 0.0001
814 RESPIRATORY ARREST 3 0.0001
815 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
816 ERYTHEMA MULTIFORME 1 0.0001
817 DIARRHOEA HAEMORRHAGIC 1 0.0001
818 HYPONATRAEMIA 6 0.0001
819 RASH ERYTHEMATOUS 5 0.0001
820 DRUG INTOLERANCE 10 0.0001
821 BONE PAIN 6 0.0001
822 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
823 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
824 BLADDER DISORDER 1 0.0001
825 BRAIN INJURY 1 0.0001
826 APHASIA 3 0.0001
827 EMPHYSEMA 1 0.0001
828 LIVER FUNCTION TEST INCREASED 2 0.0001
829 NIGHT SWEATS 3 0.0001
830 DECREASED ACTIVITY 1 0.0001
831 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
832 PRODUCT PRESCRIBING ISSUE 2 0.0001
833 DENTAL CARIES 1 0.0001
834 BLOOD PRESSURE DECREASED 6 0.0001
835 LIVER DISORDER 4 0.0001
836 STEVENS-JOHNSON SYNDROME 2 0.0001
837 BLOOD CALCIUM DECREASED 1 0.0001
838 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
839 DERMATITIS CONTACT 1 0.0001
840 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
841 ELECTROLYTE IMBALANCE 1 0.0001
842 LOSS OF CONSCIOUSNESS 11 0.0001
843 BLOOD IRON DECREASED 1 0.0001
844 ATAXIA 1 0.0001
845 MENTAL IMPAIRMENT 2 0.0001
846 HYPERSENSITIVITY 15 0.0001
847 EYE SWELLING 3 0.0001
848 DYSPNOEA EXERTIONAL 3 0.0001
849 DERMATITIS ALLERGIC 1 0.0001
850 FLUID RETENTION 4 0.0001
851 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
852 ANOREXIA 1 0.0001
853 SKIN ULCER 2 0.0001
854 BEDRIDDEN 1 0.0001
855 INFUSION RELATED REACTION 5 0.0001
856 VISION BLURRED 10 0.0001
857 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
858 HAEMATOCHEZIA 4 0.0001
859 BLINDNESS UNILATERAL 1 0.0001
860 MUSCULAR WEAKNESS 8 0.0001
861 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
862 RED BLOOD CELL COUNT DECREASED 2 0.0001
863 LABORATORY TEST ABNORMAL 2 0.0001
864 RENAL INJURY 2 0.0001
865 COLON CANCER 1 0.0001
866 CORONARY ARTERY DISEASE 2 0.0001
867 THERAPEUTIC RESPONSE DECREASED 4 0.0001
868 ANKLE FRACTURE 1 0.0001
869 CYANOSIS 1 0.0001
870 OCULAR HYPERAEMIA 3 0.0001
871 HALLUCINATION, AUDITORY 1 0.0001
872 CONDITION AGGRAVATED 19 0.0001
873 THROMBOSIS 5 0.0001
874 CHOLELITHIASIS 2 0.0001
875 OSTEONECROSIS 2 0.0001
876 HEART RATE INCREASED 6 0.0001
877 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
878 DRUG LEVEL INCREASED 1 0.0001
879 VISUAL ACUITY REDUCED 2 0.0001
880 ASTHENIA 22 0.0001
881 PAIN IN EXTREMITY 17 0.0001
882 MYOCARDIAL INFARCTION 10 0.0001
883 AMENORRHOEA 1 0.0001
884 GALLBLADDER DISORDER 1 0.0001
885 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
886 GASTROINTESTINAL DISORDER 5 0.0001
887 GOUT 1 0.0001
888 RASH PRURITIC 3 0.0001
889 CRYING 2 0.0001
890 BONE DISORDER 1 0.0001
891 END STAGE RENAL DISEASE 1 0.0001
892 ANAPHYLACTIC REACTION 3 0.0001
893 CONJUNCTIVITIS 1 0.0001
894 AGRANULOCYTOSIS 1 0.0001
895 HEPATIC CIRRHOSIS 1 0.0001
896 HALLUCINATION 4 0.0001
897 BLOOD SODIUM DECREASED 1 0.0001
898 DYSTONIA 1 0.0001
899 EAR PAIN 1 0.0001
900 WHEEZING 3 0.0001
901 BLOOD PRESSURE ABNORMAL 1 0.0001
902 FEEDING DISORDER 1 0.0000
903 ANXIETY 14 0.0000
904 BLINDNESS 2 0.0000
905 TREMOR 8 0.0000
906 HEADACHE 30 0.0000
907 DERMATITIS 1 0.0000
908 HALLUCINATION, VISUAL 1 0.0000
909 CEREBROVASCULAR ACCIDENT 8 0.0000
910 URINARY TRACT INFECTION 8 0.0000
911 DEEP VEIN THROMBOSIS 3 0.0000
912 MENTAL DISORDER 2 0.0000
913 PARAESTHESIA 7 0.0000
914 PULMONARY EMBOLISM 4 0.0000
915 BLOOD PRESSURE FLUCTUATION 1 0.0000
916 VISUAL IMPAIRMENT 5 0.0000
917 EXTRAPYRAMIDAL DISORDER 1 0.0000
918 SOMNOLENCE 8 0.0000
919 GASTRIC CANCER 1 0.0000
920 ANAPHYLACTIC SHOCK 1 0.0000
921 ABDOMINAL DISTENSION 4 0.0000
922 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
923 BLOOD GLUCOSE INCREASED 7 0.0000
924 DRY MOUTH 3 0.0000
925 ABNORMAL DREAMS 1 0.0000
926 FALL 12 0.0000
927 MYALGIA 6 0.0000
928 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
929 ACUTE MYOCARDIAL INFARCTION 1 0.0000
930 PRURITUS 13 0.0000
931 ADVERSE EVENT 3 0.0000
932 SWELLING 3 0.0000
933 BONE DENSITY DECREASED 1 0.0000
934 DYSPHAGIA 3 0.0000
935 ALOPECIA 6 0.0000
936 EYE DISORDER 1 0.0000
937 DRY SKIN 4 0.0000
938 GAIT INABILITY 1 0.0000
939 URTICARIA 5 0.0000
940 PAIN 18 0.0000
941 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
942 WEIGHT DECREASED 8 0.0000
943 BURNING SENSATION 2 0.0000
944 HEART RATE DECREASED 1 0.0000
945 DRUG EFFECT INCOMPLETE 1 0.0000
946 CONSTIPATION 6 0.0000
947 DYSURIA 1 0.0000
948 FATIGUE 21 0.0000
949 EPISTAXIS 2 0.0000
950 HOT FLUSH 2 0.0000
951 ARTHRALGIA 11 0.0000
952 UNEVALUABLE EVENT 2 0.0000
953 BACK PAIN 6 0.0000
954 COUGH 7 0.0000
955 INFLUENZA LIKE ILLNESS 2 0.0000
956 ANGIOEDEMA 1 0.0000
957 ADVERSE DRUG REACTION 2 0.0000
958 NO ADVERSE EVENT 4 0.0000
959 MUSCLE SPASMS 4 0.0000
960 NASOPHARYNGITIS 4 0.0000
961 COGNITIVE DISORDER 1 0.0000
962 CONTUSION 2 0.0000
963 DRY EYE 1 0.0000
964 CHEST DISCOMFORT 2 0.0000
965 PERIPHERAL SWELLING 3 0.0000
966 DRUG EFFECT DECREASED 1 0.0000
967 OVERDOSE 4 0.0000
968 MALAISE 8 0.0000
969 WEIGHT INCREASED 4 0.0000
970 EYE PAIN 1 0.0000
971 FLATULENCE 1 0.0000
972 COVID-19 3 0.0000
973 BLADDER CANCER 1 0.0000
974 EXPOSURE DURING PREGNANCY 1 0.0000
975 GAIT DISTURBANCE 3 0.0000
976 HYPERHIDROSIS 2 0.0000
977 AMNESIA 1 0.0000
978 ABDOMINAL PAIN UPPER 3 0.0000
979 BRONCHITIS 1 0.0000
980 DYSGEUSIA 1 0.0000
981 DIABETES MELLITUS 1 0.0000
982 HOSPITALISATION 2 0.0000
983 DRUG ABUSE 1 0.0000
984 ABDOMINAL DISCOMFORT 2 0.0000
985 BREAST CANCER 1 0.0000
986 CARDIAC DISORDER 1 0.0000
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
988 FLUSHING 1 0.0000
989 EMOTIONAL DISTRESS 1 0.0000
990 INSOMNIA 2 0.0000
991 BLOOD PRESSURE INCREASED 1 0.0000
992 FEELING ABNORMAL 1 0.0000
993 DIZZINESS 2 0.0000